Osteoporosis in Hemophilia
Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 2
Abstract
Aim: The aim of this paper is to review the pathophysiology, risk factors, prevention and treatment of osteoporosis in persons with hemophilia (PWH). Study Design and Methodology: In a search of PubMed up to September 24, 2013 using as keywords "osteoporosis" and "hemophilia" the author found 61 references, of which only the 22 focused on the aim of this study were revised. Results: Prevention of osteoporosis in PWH is crucial. Risk factors are lack of hematological prophylaxis and development of an inhibitor (antibody) against the deficient coagulation factor, lack of exercise due to chronic pain and loss of joint function (hemophilic arthropathy), low body mass index and abnormal liver function because of viral infection (HIV, HCV). It has not been demonstrated that hemophilia has any effect on osteoclast development and/or osteoblast loss. Hemophilia does not impair mineral Ca/P/K mobilizations and metabolisms. Hemophilia does not have any general effects on the endocrine system. Substitution treatment with clotting factors does not interfere with the treatment of osteoporosis. Conclusion: Continuous primary hematological prophylaxis and rehabilitation and exercise are paramount in PWH. PWH over the age of 50 should have routine screening for detection of osteoporosis. In PWH prevention should encourage good habits (such as a diet adequate in calcium and vitamin D) and discourage harmful habits (such as tobacco, alcohol and immobilization). Osteoporosis is multi-facial. Osteoporosis ought to be promptly treated regardless of the underlying cause.
Authors and Affiliations
E. Carlos Rodriguez-Merchan
Keywords
Related Articles
- EP ID EP242436
- DOI 10.9734/IBRR/2014/7122
- Views 107
- Downloads 0
Thrombin Structural and Functional Determinants as Therapeutic Targets
Thrombin is the final serine protease generated during blood coagulation. This enzyme possesses a complex and fascinating structure composed not only by an active site but also by two positively charged patches, called a...
Effect of Calpurnia aurea Seed Extract on HAART Induced Haematotoxicity in Albino Wistar Rats
Aim: To investigate the effect of Calpurnia aurea seeds extract on highly active antiretroviral therapy (HAART), first phase regimens (Lamivudine + Efavirenz + Zidovudine) induced heamtotoxicity in rats. Study Design: Th...
Variation in Blood Indices in Cases of Anemias Coexisting with HbE from Eastern India
Hemoglobin E is one of the most common forms of abnormal hemoglobin, related to hemoglobinopathies in the world. It can result in a heterogeneous group of disorders ranging from asymptomatic to severe anemia with regular...
Effects of Co-infusion of Plasma, Whole Blood and Anticogulants on Their Clotting Activities
Aims: Nafamostat mesilate (NM), a protease inhibitor is available for treating acute pancreatitis and disseminated intravascular coagulopathy and it is used as an anticoagulant for hemodialysis in Japan. A plasmapheresis...
Prophylaxis with Low Molecular Weight Heparin for Prevention of Placenta-related Recurrent Adverse Pregnancy Outcomes
Aims: To determine whether antenatal administration of low-molecular-weight-heparin (LMWH) reduces the recurrence of adverse pregnancy outcomes (APO). Study Design: Retrospective cohort study. Place and Duration of the...